Completed PHASE4 INTERVENTIONAL 2-arm NCT02645565

Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis

Comparison of Intravenous Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Proliferative Lupus Nephritis

Sponsor: Jawaharlal Institute of Postgraduate Medical Education & Research

Conditions Lupus Nephritis

Interventions Azathioprine Cyclophosphamide Methylprednisolone

Updated 7 times since 2017 Last updated: Mar 2, 2017 Started: Dec 31, 2015 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Lupus Nephritis and is currently completed. Jawaharlal Institute of Postgraduate Medical Education & Research leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Mar 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jan 2017 — Mar 2017 [monthly]

Recruiting PHASE4

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jawaharlal Institute of Postgraduate Medical Education & Research

Data source: Jawaharlal Institute of Postgraduate Medical Education & Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Puducherry, India